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body surface area [BSA] ), toxic epidermal necrolysis (TEN, ≥30% BSA), and overlap syndrome (10-29% BSA) is characterized by a widespread apoptotic destruction of the epidermis and mucous membranes. 1 Ocular involvement is observed in 75% of patients at the acute phase. 2 Severity may be classified according to Power's criteria (mild, moderate or severe involvement). 3 Ocular sequelae (OS) may result in permanent visual impairment and require prolonged follow-up. 4 Scleral lenses (SLs) are large-diameter gas-permeable contact lenses designed to cover the corneal surface and protect the cornea against tear evaporation and mechanical trauma of the pathological eyelids while improving visual acuity. SLs have been found effective in improving the comfort of patients with the most disabling OS (marked dryness, symblepharons, persistent inflammation or loss of visual acuity).
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This study aimed to determine the risk factors for disabling OS and to identify associated sequelae.
We retrospectively included all EN patients admitted to our reference center at the acute phase between 2005 and 2017 and followed for at least 6 months. The diagnosis was according to previously published clinical and histological criteria. 1 We defined disabling OS by the need to wear SLs. Indeed, in our routine practice, according to the dermatologist's and local ophthalmologist's decision, patients considered to have the most disabling OS were referred to the same ophthalmologist expert in the field of EN (AD) for SLs. We collected the following data from medical charts: 1) data on the acute phase: age, sex, Fitzpatrick skin type (I-IV vs V-VI), maximal skin detachment, highest SCORTEN 6 during the first 5 days, number of mucous membranes affected (≤ or > 3), transfer to an intensive care unit, initial ocular involvement according to Power's criteria 3 and 2) associated sequelae: cutaneous, nail, and psychiatric sequelae during follow-up.
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Demographic and clinical characteristics were expressed as mean (SD) or number (%). Differences between patients with and without SLs were investigated by univariate logistic regression, estimating odds ratios (ORs) and 95% confidence intervals (CIs). The OR significance was determined by Wald, chi-square or Fisher's exact test as appropriate, with P < .05 considered statistically significant.
Patients gave consent for the use of anonymized data and the database was declared to the
Commission Nationale Informatique et Libertés (no. 20190327153039).
Among 205 consecutive patients referred during the study period, 177 (99 females; mean [SD] age 46
[20] years) were included; 26 (15%) had an indication for SLs and were compared to 151 without SLs (Table) . The median time between the acute phase and the first SL consultation (n=20) was 1 year (6 months-6 years).
During the acute phase, the following were higher or more frequent in patients with than without SLs: Similarly, during follow-up, nail sequelae were more frequent in patients with than without SLs (54% vs 24%, p = .002), as were psychiatric disorders (58% vs 25%, p= .001). We found no association between OS and pigmentation sequelae.
Overall, 15% of our patients warranted SLs. At the acute phase, EN was more severe with than without SLs: higher percentage of detached skin, more extensive mucosal involvement, higher SCORTEN, and more severe eye damage. In our study, phototype was not associated with increased risk of development of disabling OS. However, we recently showed that among patients requiring SLs, Fitzpatrick skin type V-VI was associated with more severe ophthalmological involvement (loss of visual acuity, symblepharons, trichiasis, corneal ulcerations). 7 Thus, rigorous ophthalmologic care is needed at the acute disease phase, but consensual guidelines are lacking. 4 Encouraging preliminary results have been obtained for amniotic membrane transplantation.
8

Accepted Article
Our study emphasizes the significant association between disabling OS and other sequelae that impair quality of life (nail and psychiatric sequelae).
The limitations of our study include a probable underestimation of the number of patients requiring SL because not all patents were necessarily referred to the specialized consultation. As well, details on the severity of psychiatric sequelae were lacking because of the retrospective design.
The initial disease severity is the main risk factor for disabling OS. Initial close ophthalmologic screening and follow-up is warranted. Consensus is needed for the best ophthalmological treatment at the acute phase.
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